相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Imidazopyridines as Potent KDM5 Demethylase Inhibitors Promoting Reprogramming Efficiency of Human iPSCs
Yasamin Dabiri et al.
ISCIENCE (2019)
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
Kanaga Sabapathy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
A Ruthenium(II) N-Heterocyclic Carbene (NHC) Complex with Naphthalimide Ligand Triggers Apoptosis in Colorectal Cancer Cells via Activating the ROS-p38 MAPK Pathway
Yasamin Dabiri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells
Mohamed A. Abu el Maaty et al.
MOLECULAR CARCINOGENESIS (2017)
p21: A Two-Faced Genome Guardian
Alexandros G. Georgakilas et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Targeting the Thioredoxin System for Cancer Therapy
Junmin Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells
Yasamin Dabiri et al.
SCIENTIFIC REPORTS (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
The two faces of reactive oxygen species (ROS) in adipocyte function and dysfunction
Jose Pedro Castro et al.
BIOLOGICAL CHEMISTRY (2016)
p53 in the DNA-Damage-Repair Process
Ashley B. Williams et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Chemical biology of anticancer gold((III)) and gold((I)) complexes
Taotao Zou et al.
CHEMICAL SOCIETY REVIEWS (2015)
Gold(I) N-Heterocyclic Carbene Complexes with Naphthalimide Ligands as Combined Thioredoxin Reductase Inhibitors and DNA Intercalators
Andreas Meyer et al.
CHEMMEDCHEM (2014)
Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53
See-Hyoung Park et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells
Xinlai Cheng et al.
MOLECULAR CANCER (2014)
Gold (I) N-heterocyclic carbene complex inhibits mouse melanoma growth by p53 upregulation
Abhishek Nandy et al.
MOLECULAR CANCER (2014)
RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38
A. Weilbacher et al.
CELL DEATH & DISEASE (2014)
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
Ningning Liu et al.
ONCOTARGET (2014)
N-Heterocyclic carbene metal complexes in medicinal chemistry
Luciano Oehninger et al.
DALTON TRANSACTIONS (2013)
On the Biological Properties of Alkynyl Phosphine Gold(I) Complexes
Andreas Meyer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Regulation of p73 activity by post-translational modifications
F. Conforti et al.
CELL DEATH & DISEASE (2012)
Preparation and Characterization of Amino-Linked Heterocyclic Carbene Palladium, Gold, and Silver Complexes and Their Use as Anticancer Agents That Act by Triggering Apoptotic Cell Death
Chie-Hong Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Comparative in Vitro Evaluation of N-Heterocyclic Carbene Gold(I) Complexes of the Benzimidazolylidene Type
Riccardo Rubbiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Translating p53 into the clinic
Chit Fang Cheok et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Benzimidazol-2-ylidene Gold(I) Complexes Are Thioredoxin Reductase Inhibitors with Multiple Antitumor Properties
Riccardo Rubbiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA
Elisabeth Hedstrom et al.
CELL CYCLE (2009)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
ROS and p53: A versatile partnership
Bin Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function
L. M. S. Lau et al.
ONCOGENE (2008)
One, two, three -: p53, p63, p73 and chemosensitivity
Martina Mueller et al.
DRUG RESISTANCE UPDATES (2006)
The p53-Bcl-2 connection
M. T. Hemann et al.
CELL DEATH AND DIFFERENTIATION (2006)
Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts
Wenge Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization
Y Tomita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress
F. Murray-Zmijewski et al.
CELL DEATH AND DIFFERENTIATION (2006)
Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity
S Seemann et al.
ONCOGENE (2005)
Redox factor 1 (Ref-1) enhances specific DNA binding of p53 by promoting p53 tetramerization
S Hanson et al.
ONCOGENE (2005)
Redox activation of p21(Cip1/WAF1/Sdi1): A multifunctional regulator of cell survival and death
MA O'Reilly
ANTIOXIDANTS & REDOX SIGNALING (2005)
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
J Boyer et al.
CLINICAL CANCER RESEARCH (2004)
Defining the p53 DNA-binding domain BcL-XL-binding interface using NMR
AM Petros et al.
FEBS LETTERS (2004)
Control of apoptosis by p53
JS Fridman et al.
ONCOGENE (2003)
Regulation of p73 by c-Abl through the p38 MAP kinase pathway
R Sanchez-Prieto et al.
ONCOGENE (2002)
分享论文
